Literature DB >> 18797942

Antibody decay after immunisation of health-care workers with an acellular pertussis vaccine.

M Riffelmann1, M Littmann, C Hülsse, C H Wirsing von König.   

Abstract

Antibody decay after a single dose of acellular pertussis vaccine containing 25 microg of pertussis toxin (PT), 25 microg of filamentous hemagglutin (FHA), and traces of pertactin (PRN) was monitored in health-care workers. Blood was sampled 4 weeks (n = 246), 1 year (n = 187), 2 years (n = 53), 3 years (n = 134), and 4 years (n = 37) after vaccination. IgG anti-PT, IgG anti-FHA and IgG anti-PRN were measured by ELISA. Peak median antibodies to PT, FHA, and PRN were 314, 785, and 84 EU/ml respectively. IgG anti-PT decreased to a median of 29% (76 EU/ml), 18% (64 EU/ml), 19% (58 EU/ml), and 20% (63 EU/ml) of the peak value after 1, 2, 3, and 4 years respectively. IgG anti-FHA decreased more slowly, but showed similar decay patterns. In German health-care workers antibodies to pertussis antigens decayed rapidly within the first year after vaccination, but remained stable after 2, 3, and 4 years. This observation may have implications for the timing of booster vaccinations in adults.

Mesh:

Substances:

Year:  2008        PMID: 18797942     DOI: 10.1007/s10096-008-0625-0

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  14 in total

1.  Immunogenicity of acellular pertussis vaccines using two vaccines for primary immunization.

Authors:  C H von König; P Herden; D Palitzsch; B Schneeweiss; N Bier
Journal:  Pediatr Infect Dis J       Date:  2000-08       Impact factor: 2.129

2.  Pertussis-specific cell-mediated and humoral immunity in adolescents 3 years after booster immunization with acellular pertussis vaccine.

Authors:  Kati J Edelman; Qiushui He; Johanna P Makinen; Marjo S Haanpera; Nhu Nguyen Tran Minh; Lode Schuerman; Joanne Wolter; Jussi A Mertsola
Journal:  Clin Infect Dis       Date:  2004-07-02       Impact factor: 9.079

Review 3.  [Whooping cough--not eradicated, but forgotten].

Authors:  S Swidsinski; F L Schlesinger; S Mebel
Journal:  Z Arztl Fortbild (Jena)       Date:  1989

4.  Immunity to pertussis 5 years after booster immunization during adolescence.

Authors:  Kati Edelman; Qiushui He; Johanna Mäkinen; Anna Sahlberg; Marjo Haanperä; Lode Schuerman; Joanne Wolter; Jussi Mertsola
Journal:  Clin Infect Dis       Date:  2007-04-02       Impact factor: 9.079

Review 5.  Pertussis vaccination for health care workers.

Authors:  Thomas J Sandora; Courtney A Gidengil; Grace M Lee
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

Review 6.  Vaccines: correlates of vaccine-induced immunity.

Authors:  Stanley A Plotkin
Journal:  Clin Infect Dis       Date:  2008-08-01       Impact factor: 9.079

7.  Epidemiologic aspects and diagnostic criteria for a protective efficacy field trial of a pertussis vaccine.

Authors:  C H Wirsing von König; H J Schmitt
Journal:  J Infect Dis       Date:  1996-11       Impact factor: 5.226

8.  Evaluation of a single-sample serological technique for diagnosing pertussis in unvaccinated children.

Authors:  C H Wirsing von König; D Gounis; S Laukamp; H Bogaerts; H J Schmitt
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1999-05       Impact factor: 3.267

9.  A trial of acellular pertussis vaccine in hospital workers during the Cincinnati pertussis epidemic of 1993.

Authors:  C D Christie; K M Garrison; L Kiely; R K Gupta; J Heubi; C D Marchant
Journal:  Clin Infect Dis       Date:  2001-09-05       Impact factor: 9.079

10.  Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel.

Authors:  Katrina Kretsinger; Karen R Broder; Margaret M Cortese; M Patricia Joyce; Ismael Ortega-Sanchez; Grace M Lee; Tejpratap Tiwari; Amanda C Cohn; Barbara A Slade; John K Iskander; Christina M Mijalski; Kristin H Brown; Trudy V Murphy
Journal:  MMWR Recomm Rep       Date:  2006-12-15
View more
  6 in total

1.  Does tetanus-diphtheria-acellular pertussis vaccination interfere with serodiagnosis of pertussis infection?

Authors:  Lucia C Pawloski; Kathryn B Kirkland; Andrew L Baughman; Monte D Martin; Elizabeth A Talbot; Nancy E Messonnier; Maria Lucia Tondella
Journal:  Clin Vaccine Immunol       Date:  2012-04-25

2.  Development and analytical validation of an immunoassay for quantifying serum anti-pertussis toxin antibodies resulting from Bordetella pertussis infection.

Authors:  Sandra L Menzies; Vijay Kadwad; Lucia C Pawloski; Tsai-Lien Lin; Andrew L Baughman; Monte Martin; Maria Lucia C Tondella; Bruce D Meade
Journal:  Clin Vaccine Immunol       Date:  2009-10-28

3.  Immunization of teenagers with a fifth dose of reduced DTaP-IPV induces high levels of pertussis antibodies with a significant increase in opsonophagocytic activity.

Authors:  Audun Aase; Tove Karin Herstad; Samuel Merino; Merete Bolstad; Synne Sandbu; Hilde Bakke; Ingeborg S Aaberge
Journal:  Clin Vaccine Immunol       Date:  2011-06-15

Review 4.  Immune persistence after pertussis vaccination.

Authors:  Zhiyun Chen; Qiushui He
Journal:  Hum Vaccin Immunother       Date:  2017-01-03       Impact factor: 3.452

Review 5.  Laboratory Diagnosis of Pertussis.

Authors:  Anneke van der Zee; Joop F P Schellekens; Frits R Mooi
Journal:  Clin Microbiol Rev       Date:  2015-10       Impact factor: 26.132

6.  Pertussis toxin neutralizing antibody response after an acellular booster vaccination in Dutch and Finnish participants of different age groups.

Authors:  Aapo Knuutila; Pauline Versteegen; Alex-Mikael Barkoff; Pieter van Gageldonk; Jussi Mertsola; Guy Berbers; Qiushui He
Journal:  Emerg Microbes Infect       Date:  2022-12       Impact factor: 7.163

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.